Patents by Inventor Ta-Chiang Liu

Ta-Chiang Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for prognosing crohn's disease comprising human defensin 5 (HD5)
    Patent number: 11867701
    Abstract: The present disclosure provides methods for classifying a cell as abnormal based on HD5 protein detection as well as methods for predicting prognosis of a subject with Crohn's disease based on HD5 protein detection.
    Type: Grant
    Filed: April 27, 2017
    Date of Patent: January 9, 2024
    Assignee: Washington University
    Inventors: Thaddeus Stappenbeck, Ta-Chiang Liu, Kelli VanDussen
  • METHODS AND USES OF INFLAMMATORY BOWEL DISEASE BIOMARKERS
    Publication number: 20230313305
    Abstract: Among the various aspects of the present disclosure is the provision of methods of diagnosing and treating inflammatory bowel disease (IBD) including ulcerative colitis (UC) or Crohn's disease (CD). In particular, the present disclosure provides in part a panel of IBD biomarkers useful in diagnosing and making treatment decisions. In addition, the present disclosure provides methods of treating IBD with a plasminogen activator inhibitor-1(PAI-1) inhibitor or tissue plasminogen activator (tPA).
    Type: Application
    Filed: March 16, 2023
    Publication date: October 5, 2023
    Inventors: Thaddeus Stappenbeck, Gerard Kaiko, Ta-Chiang Liu
  • METHODS FOR PROGNOSING CROHN'S DISEASE COMPRISING HUMAN DEFENSIN 5 (HD5)
    Publication number: 20210223265
    Abstract: The present disclosure provides methods for classifying a cell as abnormal based on HD5 protein detection as well as methods for predicting prognosis of a subject with Crohn's disease based on HD5 protein detection.
    Type: Application
    Filed: April 27, 2017
    Publication date: July 22, 2021
    Applicant: Washington University
    Inventors: Thaddeus Stappenbeck, Ta-Chiang Liu, Kelli VanDussen
  • METHODS AND USES OF INFLAMMATORY BOWEL DISEASE BIOMARKERS
    Publication number: 20200165677
    Abstract: Among the various aspects of the present disclosure is the provision of methods of diagnosing and treating inflammatory bowel disease (IBD) including ulcerative colitis (UC) or Crohn's disease (CD). In particular, the present disclosure provides in part a panel of IBD biomarkers useful in diagnosing and making treatment decisions. In addition, the present disclosure provides methods of treating IBD with a plasminogen activator inhibitor-1 (PAI-1) inhibitor or tissue plasminogen activator (tPA).
    Type: Application
    Filed: July 18, 2018
    Publication date: May 28, 2020
    Inventors: Thaddeus Stappenbeck, Gerard Kaiko, Ta-Chiang Liu